Bharat Immunologicals Net Income

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Net Income Analysis

Net income is the profit of a company for the reporting period which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most watched numbers by money managers as well as individual investors.
Bharat Immunologicals 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
 = 
2.83 M

About Net Income

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin which measures income as a percentage of sales.
Compare to competition
Based on recorded statements Bharat Immunologicals Biologicals Corp Ltd reported net income of 2.83 M. This is much higher than that of the Healthcare sector, and significantly higher than that of Net Income industry, The Net Income for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Net Income Comparison
Bharat Immunologicals is currently under evaluation in net income category among related companies.

Did you try this?

Run Cryptocurrency Correlation Now
   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
All  Next Launch Cryptocurrency Correlation

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios